Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
Deals
InduPro Partners with Lilly on $950M Oncology Deal Using Proximity-Guided Platform
January 10, 2026
Company
Deals
MediLink Licenses B7H3 ADC YL201 to Roche in $850 Million Global Deal
January 10, 2026
Company
Drug
Shanghai MicuRx’s Contezolid Patent Extended Through 2033, Securing Market Exclusivity
January 10, 2026
Company
Drug
Lilly’s Taltz-Zepbound Combo Meets Primary Endpoint in Psoriatic Arthritis
January 10, 2026
Policy / Regulatory
NMPA Issues New Rules to Strengthen Pharmaceutical Contract Manufacturing Oversight
January 9, 2026
Company
Deals
Betta Pharmaceuticals Partners with Westlake University on Pharma Innovation
January 8, 2026
Company
Deals
Viva Biotech and CMS Forge AI-Powered Drug Development Alliance
January 8, 2026
Company
Deals
Hisun and ECNU Forge AI Drug Discovery Partnership
January 8, 2026
Policy / Regulatory
NMPA Issues Priority Review Guidelines for Clinically Urgent Overseas Drugs
January 8, 2026
Company
Deals
Sciclon Licenses Augtyro Promotion Rights from Zai Lab for China Market
May 8, 2026
Company
Drug
Hengrui’s Retlirafusp α Wins NMPA Approval for First-Line Gastric Cancer
January 8, 2026
Company
Deals
Pfizer Partners with Cartography on $850 Million Tumor Antigen Discovery Deal
January 8, 2026
1
2
…
190
191
192
193
194
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?